Results 251 to 260 of about 136,697 (349)

Barriers and Facilitators to Using a Clinical Decision Support Tool for Opioid Use Disorder in Primary Care [PDF]

Stephanie Ann Hooker, Leif I. Solberg, Kathleen Miley, Caitlin M Borgert-Spaniol, Rebecca C. Rossom   +4 more
openalex   +1 more source

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

Addiction, EarlyView.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu, Chia‐Chun Hung, Marc N. Potenza, Kun‐Hsien Chou, Pei‐Lin Lee, Chu‐Chung Huang, Chiang‐Shan R. Li, Tony Szu‐Hsien Lee, Ching‐Po Lin   +8 more
wiley   +1 more source

Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality

Feitong Lei, Michelle R. Lofwall, Jana McAninch, Reuben Adatorwovor, Emily Slade, Patricia R. Freeman, Daniela C. Moga, Nabarun Dasgupta, Sharon Walsh, Rachel Vickers‐Smith, Svetla Slavova   +10 more
openalex   +1 more source

Risk for prescription opioid misuse among patients with a history of substance use disorder

, 2012
Benjamin J. Morasco, Dennis C. Turk, Dennis M. Donovan, Steven K. Dobscha   +3 more
openalex   +2 more sources

The Polysubstance Assessment Tool: Reliability, acceptability and feasibility of a novel measure of polysubstance use

Addiction, EarlyView.
Abstract Background and aims There are currently no brief quantitative assessments that capture the drug patterns of people who engage in use of more than one drug on the same day or simultaneously. The current study examined the retest reliability, acceptability and feasibility of a new quantitative assessment to measure polysubstance use.
Amanda M. Bunting, Charles M. Cleland, S. Michaela Barratt, Brittany Griffin, Jaimee Williams, Carrie B. Oser, Joshua D. Lee, Jennifer McNeely   +7 more
wiley   +1 more source

Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder [PDF]

BaDoi N. Phan, Madelyn H. Ray, Xiangning Xue, Chen Fu, Robert J. Fenster, Stephen J. Kohut, Jack Bergman, Suzanne N. Haber, Kenneth M. McCullough, Madeline K. Fish, Jill R. Glausier, Qiao Su, Allison E. Tipton, David A. Lewis, Zachary Freyberg, George C. Tseng, Shelley J. Russek, Yuriy O. Alekseyev, Kerry J. Ressler, Marianne L. Seney, Andreas R. Pfenning, Ryan W. Logan   +21 more
openalex   +1 more source

Theorizing causality: A qualitative study of xylazine‐related wound diversity and perceived etiology among people who inject drugs

Addiction, EarlyView.
Abstract Background and aims Incidence and severity of opioid‐associated skin and soft‐tissue infections, often requiring intensive and costly medical care, have increased substantially since the emergence of xylazine in the US drug supply. Although progress has been made in clinical and harm reduction recommendations for treating xylazine‐related ...
Danielle German, Kelci Villarroel, Meredith Denney, Adrian Guta, Julie Evans, Jason Bienert, Alex Fidler, Kim Ashburn, Zach Kosinski, Becky L. Genberg   +9 more
wiley   +1 more source

Low-threshold Buprenorphine: Proposing the Ideal Service Model to Engage People With Severe Opioid Use Disorder. [PDF]

J Addict Med
Fox AD, Messmer SE, Hayes BT, Salisbury-Afshar E, Chatterjee A, Jakubowski AU.   +5 more
europepmc   +1 more source

Changes over time in hallucinogen‐related emergency department visits in Ontario, Canada

Addiction, EarlyView.
Abstract Background and aims Recent increasing interest in hallucinogens has underscored the critical gaps in our understanding of their adverse health effects and healthcare usage over time. The current study aimed to examine changes in emergency department (ED) visit rates involving hallucinogens, clinical outcomes of visits and the characteristics ...
Daniel T. Myran, Rachael MacDonald‐Spracklin, Alexander R. Levesque, Michael Pugliese, Jess G. Fiedorowicz, André J. McDonald, Joshua D. Rosenblat, Ian Colman, Josephine Zein, Marco Solmi   +9 more
wiley   +1 more source

Caring for Patients with Opioid Use Disorder: A Near-Peer Workshop for Medical Students. [PDF]

MedEdPORTAL
Oles WC, Lynn-Green E, Mather RV, Motoc M, Pellegrino A, Connery HS, McGuire P, Lindenberg J, Hill KP, Pelletier SR, Nelson RE, Weinstein AR.   +11 more
europepmc   +1 more source